SCHEMBL6236069

SCHEMBL6236069

C[C@@H](C[CH]C(=O)N[C@H]1CCCN(S(=O)(=O)N2CCOCC2)CC1=O)C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 6/20 0.35
HTT P42858 1/20 0.35
CYP3A4 P08684 2/20 0.34
RECQL P46063 1/20 0.34
NPC1 O15118 1/20 0.34
CTSK P43235 3/20 0.33
TSHR P16473 3/20 0.33
CTSV O60911 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.32
CYP2D6 P10635 1/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5099273 0.87 CTSK (0.40) ALDH1A1CTSKTSHRCTSVCTSL
SCHEMBL5092868 0.86 CTSK (0.35) SMN1; SMN2ALDH1A1CTSKTSHRCTSV
SCHEMBL6237786 0.85 CTSL (0.39) SMN1; SMN2ALDH1A1HTTCYP3A4RECQL
SCHEMBL4791147 0.84 CTSK (0.32) CTSKCTSVCTSLCTSBCTSS
SCHEMBL6255813 0.83 CYP3A4 (0.39) SMN1; SMN2ALDH1A1HTTCYP3A4CTSK
SCHEMBL5098864 0.83 KMT2A (0.39) SMN1; SMN2ALDH1A1NPC1CTSKTSHR
SCHEMBL4767047 0.80 CTSK (0.42) CTSKCTSVCTSLCTSBCTSS
SCHEMBL6236079 0.80 CTSK (0.42) SMN1; SMN2ALDH1A1HTTCYP3A4RECQL
SCHEMBL6404947 0.80 CTSK (0.44) CTSKCTSVCTSLCTSBCTSS
SCHEMBL5098737 0.80 ALDH1A1 (0.41) ALDH1A1CTSKTSHRCTSVCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005013909-A2 NOVEL CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-17 WO disclosed